0IGAEmergent BioSolutions Inc.
4.610USD-3.15%Mkt Cap: P/E: 1.55

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationall…

Key Statistics

Company
Market Cap
Enterprise Value683.84M $
Revenue (TTM)770.20M $
Gross Profit380.40M $
Net Income (TTM)-176.80M $
Revenue/Share14.76 USD
Last Price4.610 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees900
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS29089Q1058
Valuation
P/E (Trailing)1.55
P/E (Forward)
PEG
EV/EBITDA2.94
EV/Revenue0.89
P/S
P/B0.69
EPS (TTM)2.97
EPS (Forward)
52W Range
4.46033% of range4.920
52W High4.920 USD
52W Low4.460 USD
Profitability
Gross Margin49.39%
Oper. Margin28.34%
EBITDA Margin30.17%
Profit Margin-22.96%
ROE-40.29%
ROA6.93%
Growth
Revenue Growth66.30%
Earnings Growth
Cash Flow & Leverage
Operating CF97.70M $
CapEx (TTM)
FCF Margin4.87%
FCF Yield
Net Debt448.50M $
Net Debt/EBITDA1.93
Balance Sheet
Debt/Equity172.29
Current Ratio5.42
Quick Ratio2.69
Book Value/Sh6.655 USD
Cash/Share2.725 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.50.95M
Float49.06M
Insiders4.26%
Institutions90.67%
Technical
SMA 502.240 (+105.8%)
SMA 2004.133 (+11.5%)
Beta2.36
S&P 52W Chg20.80%
Avg Vol (30d)2.17K
Avg Vol (10d)10.76K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)